|
Alternate Name(s): |
Aneuploidy testing, maternal cell contamination studies
|
|
Specimen Requirement: |
PRENATAL: Aneuploidy testing (QF-PCR and karyotype) or Aneuploidy and copy number testing (QF-PCR and karyotype/chromosomal microarray, as indicated): - Minimum 15mL amniotic fluid (>17 mL preferable) or 10 mg chorionic villi AND 2-4 mL EDTA maternal peripheral blood (to be included with all prenatal specimens).
PERINATAL: QF-PCR or QF-PCR/chromosomal microarray, as indicated: - 1.5 cm fetal or placental* tissue in sterile transport media AND 2-4 mL EDTA maternal peripheral blood, if possible. (*note: microarray will not be performed using placental tissue)
NEONATAL/INFANT: Aneuploidy testing (QF-PCR and Karyotype, if indicated): - 1-2 mL EDTA peripheral blood AND 1-2 mL Sodium Heparin peripheral blood. NOTE: if only one collection tube is possible, EDTA is preferred.
Maternal cell contamination studies (to complement aneuploidy testing of prenatal , perinatal or cord blood specimens): - 2.4 mL EDTA peripheral blood
|
|
Turnaround Time: |
Perinatal Samples, 8 weeks.
|
|
Additional Information: |
Mothers blood is used to rule out maternal cell contamination.
For any inquiries, please contact geneticsmailbox@hhsc.ca
|
|
Method of Analysis: |
QF - PCR
|
|
Test was Last Updated: |
4/10/2024
|
|
Testing Laboratory: |
Clinical Genetics
|